Relation between type of hysterectomy and survival rate in patients with ovarian cancer - single-center study.
5-year survival rate
ovarian carcinoma
overall survival
radical hysterectomy
Journal
Przeglad menopauzalny = Menopause review
ISSN: 1643-8876
Titre abrégé: Prz Menopauzalny
Pays: Poland
ID NLM: 101263235
Informations de publication
Date de publication:
Sep 2020
Sep 2020
Historique:
received:
31
03
2020
accepted:
14
04
2020
entrez:
26
10
2020
pubmed:
27
10
2020
medline:
27
10
2020
Statut:
ppublish
Résumé
To evaluate the survival rate of patients with advanced ovarian carcinoma in relation to the type of surgical intervention - total abdominal hysterectomy with bilateral adnexectomy and omentectomy as a minimal standard compared to extended hysterectomy with a retroperitoneal approach. The study was implemented based on retrospectively obtained data from 104 patients operated on for advanced epithelial ovarian carcinoma (FIGO stages II-IV) in the period from 2004 to 2012. Total abdominal hysterectomy, bilateral adnexectomy, and omentectomy were performed on 23 patients. Extended hysterectomy with a retroperitoneal approach and varying degrees of peritonectomy, omentectomy, and appendectomy were performed on 74 patients. Seven patients were treated with adnexectomy or biopsy alone. We divided the patients into two groups according to the mode of surgery. The first one comprised the patients who underwent radical hysterectomy and the second one comprised total abdominal hysterectomy plus bilateral adnexectomy. The two groups were examined for their overall survival rate, relapse-free survival rate, and 5-year survival rate. Mean overall survival rate, relapse-free survival rate, and 5-year survival rate in the group with extended hysterectomy were higher compared to the group with total abdominal hysterectomy. The extended hysterectomy with a retroperitoneal approach with or without systematic lymph node dissection seems to be more appropriate in the surgical treatment of advanced ovarian carcinoma. The procedure is related to the improvement of survival rate as a result of the inclusion of macroscopically invisible lesions in the surgical removal.
Identifiants
pubmed: 33100945
doi: 10.5114/pm.2020.99572
pii: 41945
pmc: PMC7573335
doi:
Types de publication
Journal Article
Langues
eng
Pagination
111-116Informations de copyright
Copyright © 2020 Termedia.
Déclaration de conflit d'intérêts
The authors report no conflict of interest.
Références
Surg Oncol. 2014 Mar;23(1):40-4
pubmed: 24183480
Obstet Gynecol. 1996 Apr;87(4):532-8
pubmed: 8602304
Cancer Treat Res. 1996;81:75-87
pubmed: 8834577
Obstet Gynecol. 1991 Nov;78(5 Pt 1):879-85
pubmed: 1923216
Cancer J Sci Am. 1996 May-Jun;2(3):152-7
pubmed: 9166515
Obstet Gynecol. 2006 Jan;107(1):77-85
pubmed: 16394043
Gynecol Oncol. 2001 Oct;83(1):115-20
pubmed: 11585422
Gynecol Oncol. 2017 Feb;144(2):396-404
pubmed: 27919574
Int J Gynaecol Obstet. 2014 Jan;124(1):1-5
pubmed: 24219974
J Obstet Gynaecol Br Commonw. 1968 Nov;75(11):1155-60
pubmed: 5726929
J Am Coll Surg. 2003 Oct;197(4):565-74
pubmed: 14522325
Gynecol Oncol. 2002 Jan;84(1):53-7
pubmed: 11748976
Gynecol Oncol. 1991 Aug;42(2):151-5
pubmed: 1894175
Lancet Oncol. 2014 Jan;15(1):23-34
pubmed: 24314615
Gynecol Oncol. 2001 Dec;83(3):481-4
pubmed: 11733959